About Infa group
Infa group is a company based in Milano (Italy) founded in 1953 was acquired by Olon in May 2016. Infa group operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
- Headquarter Milano, Italy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Infa group
Detailed funding history for Infa group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Infa group
Infa group has secured backing from 1 investor. Prominent investors backing the company include OLON.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A global leader in Active Pharmaceutical Ingredients manufacturing.
|
Locked | Locked | Locked |
Investor details for Infa group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Infa group
Investment portfolio details for Infa group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Infa group
Detailed financials for Infa group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Infa Group Comparisons
Peer comparison for Infa group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Infa group
Infa group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| Locked | Locked | Locked |
APIs are manufactured and custom synthesis services are provided.
|
Detailed competitors of Infa group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Infa Group
Complete news archive for Infa group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Infa group
Infa group was founded in 1953.
Infa group is headquartered in Milano, Italy.
Infa Group is an Italian custom contract developer and manufacturer of APIs, intermediates and fine chemicals, acquired by Olon, an Italian CDMO in May 2016. Infa specializes in the custom development and manufacture of generic APIs. The therapeutic areas to which their products cater to include anti-neoplastic, antivirals, anti-inflammatory, antibiotics and other areas. Infa has 1 KiloLab, 3 Pilot cGMP Plants and 2 manufacturing sites in Italy and one in Spain. The company also offers custom synthesis services for APIs, Intermediates and fine chemicals. Apart from the supply of generic APIs, they also offer API development services right from the clinical stage. Infa Group has partnerships with 4 European Universities and is also a Member of the Italian Biocatalysis Center (IBC). The company has been granted 22 patents out of a total of 28 that it had applied. Infa offers Analytical Development and Project Management services and has capabilities to perform reactions involving Cyanuration, Bromination, Chlorination, Sodium Metal, Hydrogenation, Organometallic compounds and Ultrafiltration and reverse osmosis.
Infa group's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Infa group has 1 investor. Key investors include OLON.